Praziquantel + Pyrantel Pamoate

Verify with FDA CVM →

1,650 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,650
Total Reports
91
Deaths Reported
550.0%
Death Rate

Active Ingredients

PraziquantelPraziquantel + Pyrantel PamoatePyrantel Pamoate

Administration Routes

OralUnknownTopicalOphthalmic

Species Affected

Dog 1,516
Cat 67
Unknown 52
Human 14
Cattle 1

Most Affected Breeds

Dog (unknown) 233
Pit Bull 174
Chihuahua 139
Retriever - Labrador 104
Crossbred Canine/dog 70
Unknown 67
Shepherd Dog - German 60
Terrier - Yorkshire 51
Shih Tzu 50
Domestic Shorthair 46

Most Reported Reactions

Vomiting 673
Lethargy (see also Central nervous system depression in 'Neurological') 310
Diarrhoea 247
Not eating 140
Emesis 109
Emesis (multiple) 93
Lethargy (see also Central nervous system depression in Neurological) 86
Bloody diarrhoea 84
Drug administration error 82
Anorexia 77
Behavioural disorder NOS 75
Death 75

Outcome Breakdown

Outcome Unknown
900 (56.3%)
Recovered/Normal
574 (35.9%)
Died
81 (5.1%)
Ongoing
23 (1.4%)
Recovered with Sequela
11 (0.7%)
Euthanized
10 (0.6%)

Data Summary

Metric Value
Total adverse event reports 1,650
Reports involving death 91
Case-fatality rate (reported events) 550.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Praziquantel + Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,650 adverse event reports referencing Praziquantel + Pyrantel Pamoate, including 91 reports in which the animal died — a 550.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Praziquantel, Praziquantel + Pyrantel Pamoate, Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Topical, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Praziquantel + Pyrantel Pamoate reports are Dog (1,516 reports), Cat (67 reports), Unknown (52 reports), with Dog accounting for the largest share. Within those species, Dog (unknown) (233), Pit Bull (174), Chihuahua (139) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Praziquantel + Pyrantel Pamoate are Vomiting (673), Lethargy (see also Central nervous system depression in 'Neurological') (310), Diarrhoea (247), Not eating (140). Of the 1,599 reports with a coded outcome, Outcome Unknown is the leading category at 56.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Praziquantel + Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial